论著·临床实践

不同内膜准备方案对高龄患者冻融胚胎移植妊娠结局的影响

  • 耿文君 ,
  • 赵贝 ,
  • 严烩利 ,
  • 孔红娇 ,
  • 谈雨 ,
  • 张丽
展开
  • 河南省生殖妇产医院生殖中心 (河南 郑州 450000 )

收稿日期: 2025-11-24

  网络出版日期: 2026-03-09

基金资助

河南省属科研院所基金项目(JBKY2023008)

Different endometrial preparation protocols for frozen-thawed embryo transfer in elderly patientscomparison of pregnancy outcomes

  • Wenjun GENG ,
  • Bei ZHAO ,
  • Huili YAN ,
  • Hongjiao KONG ,
  • Yu TAN ,
  • Li ZHANG
Expand
  • Reproductive Center,Henan Provincial Reproductive and Obstetrics Hospital,Zhengzhou 450000,Henan,China

Received date: 2025-11-24

  Online published: 2026-03-09

摘要

目的 探讨高龄患者不同内膜准备方案对冻融胚胎移植妊娠结局的影响。 方法 回顾性分析2022年4月至2025年4月于河南省生殖妇产医院接受体外受精(IVF)或卵胞浆内单精子注射技术(ICSI)助孕后行冻融胚胎移植的504例高龄患者(年龄35 ~ 45岁),根据移植策略分为自然周期(NC)组(n = 102)、激素替代周期(HRT)组(n = 268)和降调节-激素替代(GnRH-a + HRT)组(n = 134)。比较3组患者的临床妊娠率、持续妊娠率、流产率、生化妊娠率,并分析影响临床妊娠因素的风险因素。 结果 (1)3组患者间的年龄、抗苗勒管激素(AMH)、体质量指数(BMI)、不孕年限、受精方式、移植胚胎类别差异均无统计学意义(P > 0.05),GnRH-a + HRT组移植日内膜厚度高于NC组和HRT组,差异有统计学意义(P < 0.05)。(2)GnRH-a + HRT组的临床妊娠率、持续临床妊娠率均高于NC组及HRT组,差异有统计学意义(P < 0.05),3组间流产率、生化妊娠率差异无统计学意义(P > 0.05)。(3)多因素logistic回归分析结果显示,年龄升高是临床妊娠的危险因素(OR = 0.896,P < 0.05),内膜厚度增加、高AMH水平是临床妊娠的保护因素(OR = 1.171、1.089,P < 0.05),移植类型、移植方案是高龄患者临床妊娠的独立危险因素。 结论 对于高龄患者,采用GnRH-a + HRT方案可以改善子宫内膜容受性,提高临床妊娠率,改善妊娠结局。GnRH-a + HRT可作为高龄患者有效的FET内膜准备方案。

本文引用格式

耿文君 , 赵贝 , 严烩利 , 孔红娇 , 谈雨 , 张丽 . 不同内膜准备方案对高龄患者冻融胚胎移植妊娠结局的影响[J]. 实用医学杂志, 2026 , 42(5) : 878 -883 . DOI: 10.3969/j.issn.1006-5725.2026.05.020

Abstract

Objective To explore the influence of different endometrial preparation regimens for elderly patients on the pregnancy outcomes of frozen-thawed embryo transfer. Methods A retrospective analysis was performed on 504 elderly patients (aged 35 ~ 45 years) who underwent frozen-thawed embryo transfer after receiving IVF or ICSI-assisted pregnancy at Henan Provincial Reproductive and Obstetrics Hospital from April 2022 to April 2025. These patients were divided into the natural cycle (NC) group (n = 102), hormone replacement cycle (HRT) group (n = 268), and down-regulation-hormone replacement (GnRH-a + HRT) group (n = 134) according to the transfer strategy. The clinical pregnancy rate, continuous pregnancy rate, miscarriage rate, and biochemical pregnancy rate of the three patient groups were compared, and the risk factors influencing clinical pregnancy were analyzed. Results (1) There were no statistically significant differences among the three groups of patients regarding age, anti-Mullerian hormone (AMH), body mass index (BMI), duration of infertility, fertilization method, and type of transplanted embryo (P > 0.05). The endometrial thickness on the transplantation day in the GnRH-a + HRT group was greater than that in the NC group and the HRT group, and this difference was statistically significant (P < 0.05). (2) Both the clinical pregnancy rate and the sustained clinical pregnancy rate in the GnRH-a + HRT group were higher than those in the NC group and the HRT group, and the differences were statistically significant (P < 0.05). There were no statistically significant differences in the miscarriage rate and biochemical pregnancy rate among the three groups (P > 0.05). (3) The results of multivariate Logistic regression analyses indicated that increased age was a risk factor for clinical pregnancy (OR = 0.896, P < 0.05), whereas increased endometrial thickness and high AMH level were protective factors for clinical pregnancy (OR = 1.171, 1.089, respectively, P < 0.05). Transplantation type and transplantation protocol are independent risk factors for clinical pregnancy in elderly patients. Conclusions For elderly patients, the GnRH-a + HRT regimen is capable of enhancing endometrial receptivity, elevating the clinical pregnancy rate, and improving pregnancy outcomes. Therefore, GnRH-a + HRT can serve as an effective endometrial preparation protocol for frozen-embryo transfer (FET) in elderly patients.

参考文献

[1] PATHARE A D S, LOID M, SAARE M, et al. Endometrial receptivity in women of advanced age: An underrated factor in infertility[J]. Hum Reprod, 2023, 29(6): 773-793. doi: 10.1093/humupd/dmad019 .
[2] XIE J, LU J, ZHANG H. Effect of GnRH agonist down-regulation combined with hormone replacement treatment on reproductive outcomes of frozen blastocyst transfer cycles in women of different ages[J]. Peer J, 2024, 12: e17447. doi: 10.7717/peerj.17447 .
[3] XU B, GEERTS D, HU S, et al. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: A randomized controlled trial and molecular mechanism study[J]. Hum Reprod, 2020, 35(6): 1306-1318. doi: 10.1093/humrep/deaa086 .
[4] HE Z, GUO N, YAO Y, et al. The effects of GnRH analogues on endometrial receptivity: A comprehensive study[J]. J Assist Reprod Genet, 2025, 42(7): 2313-2323. doi: 10.1007/s10815-025-03495-5 .
[5] WANG J, WEI M, XU A, et al. Effects of pretreatment with long-acting gonadotropin-releasing hormone agonists on pregnancy outcomes in patients with minimal and mild peritoneal endometriosis: A retrospective study of 274 frozen-thawed embryo transfer cycles. [J] Medicine (Baltimore), 2024, 103(36):e39553. doi: 10.1097/MD.0000000000039553 .
[6] VITAGLIANO A, PAFFONI A, VIGAN P. Does maternal age affect assisted reproduction technology success rates after euploid embryo transfer? A systematic review and meta-analysis[J]. Fertil Steril, 2023, 120(2): 251-265. doi: 10.1016/j.fertnstert. 2023. 02.036 .
[7] QI Q, LUO J, WANG Y, et al. Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes[J]. J Int Med Res, 2020, 48(6): 300060520918474. doi: 10.1177/0300060520918474 .
[8] XU B, HOU Z, LIU N, et al. Pretreatment with a long-acting GnRH agonist for frozen-thawed embryo transfer cycles: How to improve live birth?[J]. J Ovarian Res, 2023, 16(1): 197. doi: 10.1186/s13048-023-01277-0 .
[9] XU J, LI S Z, YIN M N, et al. Endometrial Preparation for Frozen-Thawed Embryo Transfer With or Without Pretreatment With GnRH Agonist: A Randomized Controlled Trial at Two Centers[J]. Front Endocrinol (Lausanne), 2021, 12: 722253. doi: 10.3389/fendo.2021.722253 .
[10] WU H, WEI F, TAN W, et al. Administration of depot GnRH agonist prior to programmed frozen-thawed embryo transfer does not improve the live birth rate in ovulatory women: A large, multi-center retrospective study[J]. Medicine (Baltimore), 2022, 101(40): e30991. doi: 10.1097/md.0000000000030991 .
[11] 李赛姣, 尚叶, 王笑臣, 等. 不同内膜准备方案对卵巢储备功能低下患者冻胚移植妊娠结局的影响[J]. 生殖医学杂志, 2021, 30(5): 561-567. doi: 10.3969/j.issn.1004-3845. 2021. 05.001 .
[12] 彭默然, 梁雪琪, 谭丽. 不同内膜准备方案对FET助孕结局的影响[J]. 生殖医学杂志, 2023, 32(12): 1826-1831. doi: 10.3969/j.issn.1004-3845.2023.12.010 .
[13] LI J C, WANG Y H, PENG L Y, et al. A Novel Promising Endometrial Preparation Protocol for Frozen-Thawed Embryo Transfer: A Randomized Controlled Trial[J]. Front Endocrinol (Lausanne), 2021, 12: 730059. doi: 10.3389/fendo.2021.730059 .
[14] PAN D, YANG J, ZHANG N, et al. Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen–thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure[J]. Reprod Biol Endocrinol, 2022, 20(1): 26. doi: 10.1186/s12958-022-00897-3 .
[15] LI X, LIN J, ZHANG L, et al. Effects of gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in artificial cycles: A meta-analysis[J]. Arch Gynecol Obstet, 2023, 308(3): 675-683. doi: 10.1007/s00404-022-06823-7 .
[16] 冯雨萌, 高姗, 谭季春. 冻融胚胎移植内膜准备方案的研究进展[J]. 生殖医学杂志, 2024, 33(11): 1540-1545. doi: 10.3969/ j.issn.1004-3845.2024.11.022 .
[17] ZHANG R, WANG M, ZHONG J, et al. Altered Endometrial Microbiota Profile Is Associated With Poor Endometrial Receptivity of Repeated Implantation Failure[J]. Am J Reprod Immunol, 2024, 92(5): e70005. doi: 10.1111/aji.70005 .
[18] YANG J, LU Y, ZHANG Y, et al. Acupuncture combined with gonadotropin-releasing hormone agonists improves endometrial receptivity and pregnancy outcome in patients with recurrent implantation failure of in vitro fertilization-embryo transfer[J]. J Assist Reprod Genet, 2024, 41(8): 2185-2192. doi: 10.1007/s10815-024-03140-7 .
[19] UGWU H C, ONWUZU S W I, AGBO J A, et al. Sonographic prediction of successful embryonic implantation in in-vitro fertilization and embryo transfer cycle procedures, using a multi-parameter approach[J]. Radiography (Lond), 2022, 28(2): 473-479. doi: 10.1016/j.radi.2021.11.011 .
[20] 史红珍, 王同力, 王倩, 等. 粒细胞集落刺激因子联合他达拉非对人工周期冻融胚胎移植薄型子宫内膜患者妊娠结局的改善[J]. 实用医学杂志, 2025, 41(22): 3490-3495. doi: 10.3969/ j.issn.1006-5725.2025.22.004 .
[21] 王蕾, 赵红翠, 徐阳, 等. 不同宫腔灌注方法对薄型子宫内膜患者冻融胚胎移植周期妊娠结局的影响[J]. 生殖医学杂志, 2024, 33(12): 1614-1619. doi: 10.3969/j.issn.1004-3845. 2024. 12.009 .
[22] WEI L, TIAN B, WANG S, et al. Gonadotropin Releasing Hormone Agonists Combined with Hormone Replacement Therapy Significantly Improves Reproductive Outcomes for Patients with Thin Endometrium and Intramural Fibroids in Frozen Embryo Transfer Cycles[J]. Drug Des Devel Ther, 2025, 19: 173-183. doi: 10.2147/dddt.s501809 .
[23] SUN P, DONG Y, YU Y, et al. Gonadotropin-Releasing Hormone agonist (GnRH-a) Pretreatment before Hormone Replacement Therapy Does Not Improve Reproductive Outcomes of Frozen-Thawed Embryo Transfer Cycle in Older Patients with Intrauterine Fibroid: A Retrospective Cohort Study[J]. J Clin Med, 2023, 12(4): 1401. doi: 10.3390/jcm12041401 .
文章导航

/